<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
LVTX
Lava Therapeutics
$
()


  • Lava Therapeutics reports Q4 EPS (24c), consensus (12c)

    3/20/2024 - 07:06am
  • Lava Therapeutics announces clinical development milestone achieved by Pfizer

    3/5/2024 - 07:37am
  • Fly Intel: Pre-market Movers

    1/25/2024 - 08:58am
  • Lava enters collaboration with Merk to evaluate LAVA-1207, KEYTRUDA

    1/25/2024 - 07:18am
  • Lava Therapeutics reports Q3 EPS (34c), consensus (49c)

    11/16/2023 - 07:01am
  • Lava Therapeutics price target lowered to $6 from $9 at H.C. Wainwright

    8/23/2023 - 06:06am
  • Lava Therapeutics reports Q2 EPS (48c), consensus (47c)

    8/22/2023 - 07:04am
  • Lava Therapeutics announces it will discontinue LAVA-051's clinical trial

    6/14/2023 - 09:08am
  • Lava Therapeutics expects cash to fund operations into 2026

    6/8/2023 - 07:12am
  • Lava Therapeutics reports Q1 EPS (53c), consensus (52c)

    6/8/2023 - 07:12am
  • Lava Therapeutics assumed with a Buy at Jefferies

    5/25/2023 - 05:18am
dynamic_feed Breaking News